NCI, Inc. (NCIT) Tops Q3 EPS by 2c; Guides FY11 EPS, Revs Below Views
Tweet
Share
E-mailGet Alerts NCIT Hot Sheet
Price: $20.00 --0%
Financial Fact:
Interest expense, net: 134K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense, net: 134K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NCI, Inc. (NASDAQ: NCIT) reported Q3 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $132 million versus the consensus estimate of $134.4 million.
NCI, Inc. sees FY2011 EPS of $1.08-$1.10, versus the consensus of $1.13. NCI, Inc. sees FY2011 revenue of $556-$564 million, versus the consensus of $572 million.
NCI, Inc. sees FY2011 EPS of $1.08-$1.10, versus the consensus of $1.13. NCI, Inc. sees FY2011 revenue of $556-$564 million, versus the consensus of $572 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Sandisk targets mid-to-high teens revenue growth through FY2030
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
